The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Instil Bio, Inc.(NASDAQ:TIL)


Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, ...
Website: http://instilbio.com
Founded: 2018
CEO: Bronson Crouch
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Instil Bio . Days Payable Outstanding ttm (DPO)
Instil Bio . Days Receivable Outstanding ttm (DSO)
Instil Bio . Op Cashflow Per Share ttm
Instil Bio . Free Cashflow Per Share ttm
Instil Bio . Cash Per Share ttm
Instil Bio . P/S ratio ttm
Instil Bio . (GAAP) P/E ratio ttm
Instil Bio . P/B ratio ttm
No extra charts and metrics for this ticker.